Document Page: First | Prev | Next | All | Image | This Release | Search

File: 123096_sep96_decls30_0002.txt
Page: 0002
Total Pages: 34

Subject: MEDICAL BIOLOGIC WARFARE DEFENSE                                

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003203

Folder Title: MED BIO WARFARE DEFENSE INFORMATION PAPER AND SLIDES                                            

Document Number:          1

Folder Seq  #:        246










                                     INFORMATION PAPER


                                                                      10 Sep 91
                                                                      DASG-HCD



         SUBJECT: BIOLOGICAL DEFENSE VACCINE PROGRAM STATUS

         1. PURPOSE: To update the Surgeon General on the status of the
         medical biological warfare defense activities.

         2. FACTS

             a. The Under-Secretary of Defense named the Army as the
         Executive Agent for the Biological Warfare Defense Program
         26 Aug 91.

             b. ODSOPS, MG Del Rosso, is responsible for collecting the
         information for the proposed Tank brief on this subject. We are
         actively supporting him.

                   (1) The Biological Defense General Officer Steering
         Committee (BD GOSC) chaired by MG Del Rosso, Director, Space and
         Special Weapons met 29 Aug 91. Working Groups of the Committee
         are:

                         Bio-Detection and Early Warning (Navy)
                         Decontamination (Marines)
                         Physical Protection (Air Force)
                         Policy and Vaccine Production (Army)

                   (2) The Vaccine Production and Policy Working Group,
         chaired by BG Blanck, provided cost estimates and
         recommendations.

             C. The Army indemnified the National Cancer Institute
         (Program Resources, Inc.) to produce anthrax vaccine. This
         action increases our ability to produce both anthrax and
         botulinum toxoid.

             d. MG Travis is scheduled to brief BG Blanck on MRDC efforts
         Friday, 0900, 13 Sep 91. Briefed will be production schedules
         and Desert Storm follow-up research efforts.

             e. BG Blanck is scheduled to meet with MG Del Rosso Friday,
         1530, 13 Sep 91)to discuss U.S. production capabilities.



                                                MAJ KLENKE/DASG-HCD/756-8163

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 34 f:/Week-36/BX003203/MED BIO WARFARE DEFENSE INFORMATION PAPER AND SLIDES/medical biologic warfare defense:12179609282531
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = MED BIO WARFARE DEFENSE INFORMATION PAPER AND SLIDES
Folder Seq # = 246
Subject = MEDICAL BIOLOGIC WARFARE DEFENSE
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996